Blog

With complex oncology studies, mid-study changes are the norm, but disruptions from downstream impacts don’t have to be. Here are 5 supply chain impacts resulting from master protocol amendments– and how to best prepare.

With master protocols, each site has to perform its own approval process in order to begin working under a new protocol version, resulting in multiple protocol versions being used at the same time. How can you manage this? Here are 3 simple steps.

A master protocol acts like a map showing many paths a clinical trial may take, where the sponsors don’t know in which direction their study will evolve, until the trial is under way.

Q&A with a clinical research site discussing COVID-19 and the movement towards Direct-to-Patient trials.

Direct-to-Patient (DtP) trials are more prevalent than ever before. Here are 5 questions to ask yourself when planning a DtP trial.

In this interview, two senior industry clinical trial supply professionals discuss experiences with manual tools and existing commercial solutions, as well as the need for an improved clinical supply forecasting solution.

Integrations don't need to involve complicated coding to develop. Modern tech can simplify implementation and enable a conversation between systems.

Excel is a great tool for planning. It's easy to use and for experienced users provides insight into data. But is it the best choice for your trial?

CSPs should be empowered with a good level of understanding what variables or information is critical to model supply planning (feasibility planning to study planning) so they can react and make decisions more effectively.